Phase 2 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part and have signed a consent form agreeing to join the study
- You are between 18 and 75 years old
- You have been diagnosed with stomach cancer or cancer at the junction of the stomach and food pipe, confirmed by a tissue test
- Your cancer cells have tested negative for a specific protein marker called MHC-II (confirm with trial site)
- Your cancer has been assessed by scans and/or keyhole surgery as being at a certain stage — it has grown into surrounding tissue and spread to nearby lymph nodes, but not to distant parts of the body (confirm with trial site)
- You have not received any previous treatment for this cancer, such as surgery, radiotherapy, chemotherapy, targeted therapy, or immunotherapy
- You are planned to have surgery after completing the pre-surgery treatment used in this trial
- You are able to swallow tablets
- You are generally well enough to carry out light daily activities (your doctor will assess this)
- You are expected to live for at least 6 months
Who may not be able to join:
- You are pregnant, breastfeeding, or planning to become pregnant within 6 months before, during, or after the last dose of the trial treatment
- You have signs of active bleeding from your tumour or a related area
- Your cancer has been identified as having a specific genetic feature called dMMR or MSI-H (confirm with trial site)
- You have a blockage or near-blockage in your food pipe or the lower part of your stomach that affects eating, digestion, or your ability to swallow tablets
- You still have side effects from a previous cancer treatment that have not fully resolved, with some exceptions (confirm with trial site)
- You have a known deficiency of an enzyme called DPD, or you have previously had a severe mouth or gut reaction to a fluorouracil-based chemotherapy drug
- You have had a severe allergic reaction to any antibody-based medicine or to the chemotherapy drugs used in this trial (capecitabine or oxaliplatin)
- You have a history of epileptic seizures, or have untreated or active cancer spread to the brain or spinal cord
- You have a significant heart or blood vessel condition (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13968032995
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathological Complete Response (pCR) rate of ITT population
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.